BPC 157 Explained: Benefits, Risks, and What the Research Actually Shows BPC 157 Research Guide Canada Dosing, Mechanism & Sourcing BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved BPC 157 + TB 500 Combination: Benefits, Differences, and When to Use Both Revolution Health & Wellness Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs